More thyroid medicines recalled for being too weak. People have reported problems
Testing and customer complaints of medical problems resulted in two lots of NP Thyroid tablets getting recalled by manufacturer Acella Pharmaceuticals.
NP Thyroid got pulled for subpotency, the same reason Nature-Throid and WP Thyroid got pulled by RLC Labs earlier this month. The Acella-written, FDA-posted recall notice says the tablets “may have as low as 87% of the labeled amount of levothyroxine (T4).”
In simplest terms, that means the medicine could be too weak to work. And the notice admits, as of Thursday, “Acella has received four reports of adverse events for these lot numbers possibly related to this recall.”
Those lots numbers are M327E19-1 for NP Thyroid 15, 1/4 grain (15 mg) tablets, expiration date October 2020; and M328F19-3 for NP Thyroid 120, 2 grain (120 mg) tablets, expiration date November 2020.
Anyone with questions about the recall can email recall@acellaphrama.com or call 888-280-2044, Monday through Friday, from 8 a.m. to 5 p.m.., Eastern time.
Those who suffer a medical problem from this or any other drug should first contact a medical professional. Then, report it to the FDA’s MedWatch Adverse Event Reporting program either via the FDA website or by a form obtained at 800-332-1088.
These 18 hand sanitizers have been added to FDA’s Do Not Use List in the past 19 days
